Surgery and Prophylaxis with Susoctocog-Alfa in Acquired Hemophilia: Case Series and Literature Review

Background: Acquired hemophilia A (AHA) is a rare bleeding disease due to autoantibodies directed against clotting factor VIII (FVIII). Treatment of AHA consists of inhibitor eradication with immunosuppressive therapy (IST) and prompt control of bleeding obtained with bypassing agents or recombinant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sella, Carola, Bardetta, Marco, Valeri, Federica, Dainese, Cristina, Valpreda, Alessandra, Massaia, Massimo, Grimaldi, Daniele, Porreca, Annamaria, Bruno, Benedetto, Borchiellini, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380857/
https://www.ncbi.nlm.nih.gov/pubmed/37510704
http://dx.doi.org/10.3390/jcm12144590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380857/
https://www.ncbi.nlm.nih.gov/pubmed/37510704
http://dx.doi.org/10.3390/jcm12144590

Ejemplares similares